Key result
Temocapril treatment for 12 weeks significantly attenuated alterations in mitochondrial and MB-CK fractions and improved LV remodeling and function compared with untreated rats after MI.
Why the study?
Does temocapril improve the myocardial intracellular creatine kinase system and left ventricular function in rats with heart failure after myocardial infarction?
Population
Rats with heart failure after myocardial infarction (MI) induced by left coronary artery occlusion (n=63)
Comparison
Temocapril 80 mg/L in drinking water for 4 weeks… vs Untreated MI rats and sham-operated normal…
Design
Preclinical, Rats were randomized to either an ACE inhibitor group or placebo…
Follow-up
4 weeks and 12 weeks
Authors
Loading...
Supports ACE inhibition effects on post-MI energy metabolism in rats; leaves open clinical translation to human HF.
Does temocapril improve the myocardial intracellular creatine kinase system and left ventricular function in rats with heart failure after myocardial infarction?
ACE inhibition with temocapril progressively improves myocardial energy metabolism and attenuates left ventricular remodeling in a rat model of chronic heart failure after myocardial infarction, with benefits most apparent at 12 weeks.
Hironaka et al. (2003) studied Heart failure after myocardial infarction. Temocapril vs. Untreated MI rats was evaluated on Changes in myocardial intracellular creatine kinase (CK) system, LV remodeling, and function. Temocapril treatment for 12 weeks significantly attenuated alterations in mitochondrial and MB-CK fractions and improved LV remodeling and function compared with untreated rats after MI.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: